Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

被引：235

作者：

Curigliano, G. ^{[1
,2
]}

Banerjee, S. ^{[3
,4
]}

Cervantes, A. ^{[5
,6
]}

Garassino, M. C. ^{[7
]}

Garrido, P. ^{[8
]}

Girard, N. ^{[9
,10
]}

Haanen, J. ^{[11
]}

Jordan, K. ^{[12
]}

Lordick, F. ^{[13
]}

Machiels, J. P. ^{[14
,15
]}

Michielin, O. ^{[16
]}

Peters, S. ^{[16
]}

Tabernero, J. ^{[17
,18
]}

Douillard, J. Y. ^{[19
]}

Pentheroudakis, G. ^{[20
]}

机构：

[1] IRCCS, European Inst Oncol, Dept Oncol & Hematooncol, Div Early Drug Dev, Milan, Italy

[2] Univ Milan, Milan, Italy

[3] Royal Marsden NHS Fdn Trust, Gynaecol Unit, London, England

[4] Inst Canc Res, London, England

[5] Univ Valencia, Biomed Res Inst, INCLIVA, Dept Med Oncol, Valencia, Spain

[6] CIBERONC Inst Salud Carlos III, Hematol & Med Oncol, Madrid, Spain

[7] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy

[8] Univ Alcala, Hosp Univ Ramon y Cajal, Med Oncol, Madrid, Spain

[9] Univ Lyon, Univ Claude Bernard Lyon, Thorac Oncol, Lyon, France

[10] Inst Curie, Dept Oncol Med, Thorac Surg, Paris, France

[11] Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands

[12] Heidelberg Univ, Dept Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany

[13] Univ Leipzig, Univ Canc Ctr Leipzig, Dept Inst Roi Albert II, Med Ctr, Leipzig, Germany

[14] Catholic Univ Louvain, Inst Roi Albert II, Serv Oncol Med, Clin Univ St Luc, Brussels, Belgium

[15] Catholic Univ Louvain, Inst Rech Clin & Expt POLE MIRO, Brussels, Belgium

[16] Lausanne Univ Hosp CHUV, Dept Oncol, Lausanne, Switzerland

[17] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

[18] Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[19] Ctr Rene Gauducheau, Dept Med Oncol, Nantes, France

[20] Univ Ioannina, Med Sch, Dept Med Oncol, Ioannina, Epirus, Greece

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 10期

关键词：

COURSE RADIOTHERAPY; LUNG-CANCER;

D O I：

10.1016/j.annonc.2020.07.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.

引用

页码：1320 / 1335

页数：16

共 55 条

[1] How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, Roy M.
Heesterbeek, Hans
Klinkenberg, Don
Hollingsworth, T. Deirdre
[J]. LANCET, 2020, 395 (10228) : 931 - 934
[2] End coronavirus stigma now
不详
[J]. NATURE, 2020, 580 (7802) : 165 - 165
[3] [Anonymous], INF HEALTHC PROF COR
[4] [Anonymous], Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases
[5] [Anonymous], LANCET
[6] [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)31173-9
[7] [Anonymous], NAT MED
[8] Immunological effects of BRAF plus MEK inhibition
Ascierto, Paolo A.
Dummer, Reinhard
[J]. ONCOIMMUNOLOGY, 2018, 7 (09):
[9] SARS-CoV-2 shedding and infectivity
Atkinson, Barry
Petersen, Eskild
[J]. LANCET, 2020, 395 (10233) : 1339 - 1340
[10] Barlesi F, 2020, AM ASS CANC RES AACR

← 1 2 3 4 5 6 →